Executive Director, Head of Toxicology
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and CompanyAbout the role
<p><strong>Description of Role</strong></p> <p><span data-contrast="auto">Centessa Pharmaceuticals is seeking an Executive Director/Head of Toxicology to provide scientific and strategic leadership for nonclinical safety across discovery and development programs, with an emphasis on small</span>‑<span data-contrast="auto">molecule therapeutics. This role leads toxicology and safety pharmacology strategy to support target selection, lead optimization, IND</span>‑<span data-contrast="auto">enabling activities, and clinical advancement. Reporting to our SVP, Nonclinical & Translational Development</span><strong><em><span data-contrast="auto">, </span></em></strong><span data-contrast="auto">the Head of Toxicology partners closely with cross</span>‑<span data-contrast="auto">functional teams and represents nonclinical safety in regulatory interactions while building a strong, high</span>‑<span data-contrast="auto">performing toxicology organization.</span><span data-ccp-props="{}"> </span></p> <p><strong>Key Responsibilities</strong></p> <ul> <li>Lead and mentor a team of toxicologists and technical/operational staff, fostering scientific excellence and professional growth</li> <li>Define and execute nonclinical safety strategies across discovery, preclinical, and clinical stages</li> <li>Provide expert toxicology and safety pharmacology input to cross‑functional development teams</li> <li>Lead nonclinical sub‑teams as an integrated development head, providing cross‑functional oversight across Toxicology, DMPK, Bioanalytical Sciences, and Clinical Pharmacology to ensure aligned, program‑ready nonclinical strategies</li> <li>Serve as the primary nonclinical representative on Program Development Teams (PDTs) and at internal governance and external forums, effectively championing program strategy, presenting to regulatory authorities, and holding scientific ground with senior leadership, partners, CROs, and health authorities</li> <li>Design, oversee, and interpret GLP, non‑GLP, investigative, and in vitro toxicology studies</li> <li>Develop safety strategies for new targets, lead optimization programs, and platform technologies</li> <li>Oversee toxicology and safety pharmacology studies conducted internally and at CROs</li> <li>Ensure high scientific quality, compliance, and timely delivery of nonclinical study outputs</li> <li>Author and critically review toxicology sections of regulat
Apply for this role
Generate a tailored application kit with a matched cover letter, interview prep, and CV highlights — in under 60 seconds.
Apply Now →Generate Application KitFree account required — sign up in 30s
Company
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and CompanyView company profile →